NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

醫療保健行業的前景(∼2025年):醫療保健成本的上漲和改善患者結果方面的失衡推動了全球醫療保健行業的災難性變化

Vision 2025-Rising Healthcare Expenditures and Disproportionate Improvement in Patient Outcomes Spur Disruptive Changes in the Global Healthcare Industry

出版商 Frost & Sullivan 商品編碼 981751
出版日期 內容資訊 英文 53 Pages
商品交期: 最快1-2個工作天內
價格
醫療保健行業的前景(∼2025年):醫療保健成本的上漲和改善患者結果方面的失衡推動了全球醫療保健行業的災難性變化 Vision 2025-Rising Healthcare Expenditures and Disproportionate Improvement in Patient Outcomes Spur Disruptive Changes in the Global Healthcare Industry
出版日期: 2020年12月09日內容資訊: 英文 53 Pages
簡介

全球醫療保健行業正處於重大變革之中,這一過程因COVID-19大流行而加速了。幾種大趨勢和顛覆性技術正在融合,以推動整個醫療保健生態系統的這種轉型。

本報告著眼於醫療保健行業的前景,重點關注以患者為中心的患者護理方面,以及現在和將來的生物製藥公司,醫療設備公司,診斷公司,數字健康和醫療保健。詳細介紹以患者為中心的轉變對每個行業利益相關者(包括IT公司)意味著什麼。

目錄

戰略勢在必行

  • 為什麼增長變得越來越困難?
  • 戰略帝國8
  • 前三項戰略要務對醫療保健行業的影響
  • 增長機會助推增長管道引擎

增長機會分析:醫療保健行業

  • 醫療保健行業的關鍵增長指標
  • 護理重點轉移:從 "疾病護理" 到 "醫療保健" 再到健康
  • 醫療保健公司適應此新範式的四個目標和不斷變化的角色
  • 醫療保健行業在轉型中繼續增長
  • 製藥公司仍然是最大的部門,但醫療IT增長最快
  • 融合技術和醫療保健以實現四個目標
  • 推動醫療保健和生命科學領域轉型的趨勢
  • 醫療保健行業的增長動力
  • 醫療保健行業的增長限制

增長機會分析:2025年的醫療保健行業

  • 患者是消費者,他們的興趣擴展到了診斷前和治療後
  • 患者消費者:2025年的行為領域
  • 提供護理--2025-準確性:隨時隨地
  • 提供護理:2025年的行動領域
  • 2025年護理團隊:新成員,包括您自己成為護理團隊的一員
  • 護理團隊:2025年行動領域
  • 醫療設備-2025
  • 醫療器械:2025年的行動領域
  • 生物製藥-2025
  • 生物製藥:2025年的行為領域
  • 診斷2025
  • 診斷:2025年的行為領域
  • Digital Health--2025
  • 數字健康:2025年的行動領域

增長機會宇宙:對醫療保健行業的影響

  • 患者參與界面在實現醫療保健目標中的作用
  • 關聯和量化的患者
  • 通過物聯網和大數據分析實現精準健康
  • 數據是數字時代醫療保健的新貨幣
  • 商業化和技術成熟的時間表

增長機會宇宙:醫療保健行業

  • 增長機會1:智能虛擬助手可改善醫療保健的消費者體驗
  • 增長機會2:智能成像設備可提高臨床效率
  • 增長機會3:用於早期診斷的智能篩選設備
  • 增長機會4:AI代表壽命,健康和治療
  • 增長機會5:將臨床基因組學(NGS)和基於mHealth的診斷方法整合到標準治療中
  • 圖表列表
  • 免責聲明
目錄
Product Code: K57A-54

Technology-driven Transformation Offers Future Growth Potential for Stakeholders

The global healthcare industry is in the midst of a major transformation, a process that was accelerated by the COVID-19 pandemic. Several mega trends and disruptive technologies have converged to drive this transformation across the healthcare ecosystem. In this study, Frost & Sullivan builds upon previous analysis on the future of healthcare for the year 2025.

This research takes a deep dive into the aspect of patient care, with the patient as the focal point. It takes a deeper look at what the patient-centric shift means for each of the industry's stakeholders: biopharmaceutical companies, medical device companies, diagnostics companies, digital health, and health IT companies, today and in 2025.

The changes expected in 2025 must be understood and prepare for now, so Frost & Sullivan provides a 2025 view of who the patient will be, what care delivery will look like, and how care delivery teams will function in the near term. The goal is to move closer to the quadruple aim of healthcare, leveraging several technologies that are emerging today. This study also provides a representative growth opportunity for each of the industry sectors, offering a taste of what is to come for the broader healthcare industry.

Table of Contents

Strategic Imperatives

  • Why is it Increasingly Difficult to Grow?
  • The Strategic Imperative 8™
  • The Impact of the Top Three Strategic Imperatives on the Healthcare Industry
  • Growth Opportunities Fuel the Growth Pipeline Engine™

Growth Opportunity Analysis-Healthcare Industry

  • Key Growth Metrics for Healthcare Industry
  • Shifting Focus of Care-From 'Sickcare' to 'Healthcare' to Health
  • The Quadruple Aim and the Shifting Role of Healthcare Companies to Fit into this New Paradigm
  • Healthcare Industry Continues to Grow amidst Transformation
  • Pharma Remains the Largest Sector, but Health IT Growing the Fastest
  • Convergence of Technology and Healthcare to Achieve Quadruple Aim
  • Trends Driving Transformation in Healthcare and Life Sciences
  • Growth Drivers for the Healthcare Industry
  • Growth Restraints for the Healthcare Industry

Growth Opportunity Analysis-Healthcare Industry in 2025

  • Patients are Consumers, and Their Focus has Extended to Pre-diagnosis and Post-treatment
  • Patient Consumers-Areas of Action for 2025
  • Care Delivery in 2025-Precise: Anytime, Anywhere
  • Care Delivery-Areas of Action for 2025
  • Care Teams in 2025-New Members, Including Oneself, as Part of the Care Team
  • Care Teams-Areas of Action for 2025
  • Medical Devices in 2025
  • Medical Devices-Areas of Action for 2025
  • Biopharma in 2025
  • Biopharma-Areas of Action for 2025
  • Diagnostics in 2025
  • Diagnostics-Areas of Action for 2025
  • Digital Health in 2025
  • Digital Health-Areas of Action for 2025

Growth Opportunity Universe-Healthcare Industry Implications

  • The Role of the Patient Engagement Interface in Achieving Healthcare Targets
  • Connected and Quantified Patient
  • Precision Health Enabled Through IoT and Big Data Analytics
  • Data is the New Currency for Healthcare in the Digital Age
  • Technology Commercialization and Maturation Timeframe

Growth Opportunity Universe-Healthcare Industry

  • Growth Opportunity 1: Intelligent Virtual Assistants to Enhance the Healthcare Consumer Experience, 2020
  • Growth Opportunity 1: Intelligent Virtual Assistants to Enhance the Healthcare Consumer Experience, 2020 (continued)
  • Growth Opportunity 2: Intelligent Imaging Devices to Enhance Clinical Efficiency, 2020
  • Growth Opportunity 2: Intelligent Imaging Devices to Enhance Clinical Efficiency, 2020 (continued)
  • Growth Opportunity 3: Smart Screening Devices for Early Diagnosis, 2020
  • Growth Opportunity 3: Smart Screening Devices for Early Diagnosis, 2020 (continued)
  • Growth Opportunity 4: AI for Longevity, Wellness, and Curative Therapies, 2020
  • Growth Opportunity 4: AI for Longevity, Wellness, and Curative Therapies, 2020 (continued)
  • Growth Opportunity 5: Integration of Clinical Genomics (NGS) and mHealth-based Diagnostics into Standard Care, 2020
  • Growth Opportunity 5: Integration of Clinical Genomics (NGS) and mHealth-based Diagnostics into Standard Care, 2020 (continued)
  • List of Exhibits
  • Legal Disclaimer